Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • Access to Data and Biospecimens, 2017
    LRRK2 in predicting Parkinson disease risk and progression in LRRK2 mutation carriers

    Study Rationale:       

    The G2019S mutation in the LRRK2 gene is responsible for thousands Parkinson disease (PD) cases. But, not all of the mutation carriers will develop PD. Currently, clinicians...

  • Research Grant, 2016
    Investigation of the Role of PINK1-dependent Phosphorylation of Rab GTPases in Parkinson’s Disease

    Study Rationale:
    Mutations in the PINK1 gene lead to Parkinson’s disease. PINK1 belongs to a special class of enzymes known as protein kinases. We recently found that PINK1 targets a family of enzymes...

  • Priority Target Award, 2016
    Advancing PINK1 Knockout Models of Parkinson’s

    Study Rationale:
    Loss-of-function mutations in PINK1 are causally linked to early-onset Parkinson’s disease (PD). MJFF funded the generation and initial characterization of PINK1 knockout (KO) models...

  • Research Grant, 2016
    Production of Helper Dependent Adenovirus Type 5 LRRK2 Expression Vectors

    Study Rationale:                   
    The LRRK2 gene has been implicated in Parkinson’s disease, but is too large to be expressed in viral vectors, a tool to modify cells. In order to study LRRK2...

  • Target Advancement Program, 2016
    Biochemical Analysis and Structural Determination of LRRK2 with Kinase Inhibitors

    Study Rationale:                   
    Although pharmacological and surgical treatments are available to manage the symptoms of Parkinson’s disease (PD), none yet can slow down or stop the course of the...

  • Improved Biomarkers and Clinical Outcome Measures, 2016
    Developing a Molecular Imaging Tool That Binds to Alpha-Synuclein and Inhibits Its Formation

    Study Rationale:
    Amyloid fibrils play a key role in Parkinson's disease (PD). Studying their formation from self‐assembled aggregates (protein clumps) would help aid the development of a valuable...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.